Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Arthritis Research & Therapy|December 4, 2016
Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohortsMichael Ziegelasch, Myrthe A M van Delft, Philip Wallin, et al.
Lupus|April 20, 2017
Neuropsychiatric symptoms in systemic lupus erythematosus: impact on quality of lifeR C Monahan, L J J Beaart-van de Voorde, G M Steup-Beekman, et al.
Clinical Rheumatology|January 19, 2011
Needs and preferences regarding health care delivery as perceived by patients with systemic sclerosisAnne A Schouffoer, Elisabeth J M Zirkzee, Stella M Henquet, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 3, 2010
Perfusion MRI in neuro-psychiatric systemic lupus erthemathosusBart J Emmer, Matthias J van Osch, Ona Wu, et al.
AJNR. American Journal of Neuroradiology|November 16, 2005
The effect of corticosteroid medication on quantitative MR parameters of the brainStefan C A Steens, Gerda M Steup-Beekman, Gerlof P Th Bosma, et al.
Lupus|July 20, 2011
Health care usage in Dutch systemic lupus erythematosus patientsE J M Zirkzee, G M Steup-Beekman, A A Schouffoer, et al.
Clinical Rheumatology|April 19, 2014
Health care in systemic lupus erythematosus (SLE): the patient's perspectiveE J M Zirkzee, G M Steup-Beekman, A A Schouffoer, et al.
Frontiers in Immunology|January 14, 2017
C1q Deficiency and Neuropsychiatric Systemic Lupus ErythematosusRosanne A van Schaarenburg, César Magro-Checa, Jaap A Bakker, et al.
European Journal of Immunology|August 21, 2024
Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosusStef van der Meulen, Rory C Monahan, Kyra A Gelderman, et al.
Pageof 10